FDA authorizations remain the decisive factor shaping trader views on JUUL flavor relaunches in the United States by year-end 2026. The August 2026 marketing orders for the JUUL2 device and its tobacco- and menthol-flavored pods (18 mg/mL) built on the July 2025 approvals for Virginia Tobacco and Menthol variants, confirming the agency’s willingness to greenlight menthol while still requiring premarket tobacco product applications for any additional profiles. JUUL has publicly stated it will pursue further filings for higher-nicotine strengths and a portfolio of adult-oriented flavors, citing internal development of options beyond tobacco and menthol, yet no fruit, mint, or crème-brûlée products have received U.S. clearance. International JUUL2 launches of mango, watermelon, and similar flavors demonstrate product readiness but do not affect U.S. resolution criteria. Traders are therefore watching submission timelines, FDA review pace, and any draft guidance updates that could accelerate or constrain expanded approvals before December 31.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วWhich flavors will JUUL relaunch in 2026?
Mango
46%
Mint
52%
Cucumber
52%
Fruit Medley
28%
Crème Brûlée
20%
$1,041 ปริมาณ
Mango
46%
Mint
52%
Cucumber
52%
Fruit Medley
28%
Crème Brûlée
20%
A relaunch is defined as JUUL making the specified flavor commercially available for purchase by consumers in the United States, whether through retail, direct-to-consumer, or other distribution channels. A limited release, test market, or sampling program will not constitute a relaunch.
A flavor will be considered to be the same as the specified flavor as long as the listed flavor name is entirely included in the released flavor’s name (e.g. if Juul launches “Cool Cucumber”, the option for “Cucumber” would resolve to “Yes”). Minor differences in capitalization, punctuation, or accenting will not affect this market’s resolution.
The primary resolution source for this market will be official information from Juul; however, a consensus of credible reporting may also be used.
Note: This market resolves based on commercial availability in the United States only. International relaunches will not be considered for resolution purposes.
ตลาดเปิดเมื่อ: May 11, 2026, 9:33 PM ET
ผู้ตัดสินผล
0x65070BE91...A relaunch is defined as JUUL making the specified flavor commercially available for purchase by consumers in the United States, whether through retail, direct-to-consumer, or other distribution channels. A limited release, test market, or sampling program will not constitute a relaunch.
A flavor will be considered to be the same as the specified flavor as long as the listed flavor name is entirely included in the released flavor’s name (e.g. if Juul launches “Cool Cucumber”, the option for “Cucumber” would resolve to “Yes”). Minor differences in capitalization, punctuation, or accenting will not affect this market’s resolution.
The primary resolution source for this market will be official information from Juul; however, a consensus of credible reporting may also be used.
Note: This market resolves based on commercial availability in the United States only. International relaunches will not be considered for resolution purposes.
ผู้ตัดสินผล
0x65070BE91...FDA authorizations remain the decisive factor shaping trader views on JUUL flavor relaunches in the United States by year-end 2026. The August 2026 marketing orders for the JUUL2 device and its tobacco- and menthol-flavored pods (18 mg/mL) built on the July 2025 approvals for Virginia Tobacco and Menthol variants, confirming the agency’s willingness to greenlight menthol while still requiring premarket tobacco product applications for any additional profiles. JUUL has publicly stated it will pursue further filings for higher-nicotine strengths and a portfolio of adult-oriented flavors, citing internal development of options beyond tobacco and menthol, yet no fruit, mint, or crème-brûlée products have received U.S. clearance. International JUUL2 launches of mango, watermelon, and similar flavors demonstrate product readiness but do not affect U.S. resolution criteria. Traders are therefore watching submission timelines, FDA review pace, and any draft guidance updates that could accelerate or constrain expanded approvals before December 31.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว



ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย